| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Investing > Annuities - Avoid More Financial Razor Blades |
|
Top Articles - Annuities - Avoid More Financial Razor Blades
Our nation has just enjoyed one of its most popular annual rituals: the Super Bowl. One can draw many lessons from the drama on the gridiron and all the hoopla surrounding it. But as I watched this year’s spectacle, one thing in particular caught my eye. A According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product nd what I saw can teach a very valuable lesson about investing. Why do so many Americans watch the Super Bowl every year, anyway? For the commercials, of course! And every year, companies try to wow us with their outrageous ads, or use the national spotli ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ght to launch their newest product. This year was no exception, as one famous consumer products company introduced a ground-breaking improvement: a razor with five blades. That’s right, not a razor with four blades, which is so old-fashioned, but one with lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. five, yes, count them, five blades! Razor blade companies aren’t the only ones trying to sell us on the latest and greatest must-have upgrades. Have you shopped for toothpaste lately? Talk about brand extension! Why do products that work fine to start w here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ith need to be upgraded and improved? There is one reason: sales. If one company comes out with a new improved version, it means that all of its competitors have to also. Otherwise, they might lose sales to the improved version. These improvements aren’t d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro free. Take a quick look at the cost of a five-blade razor and you realize all these bells and whistles carry a hefty price tag, especially when compared to the ‘old-fashioned’ version. The same ‘brand extension’ occurs in the financial industry as well. T ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc hey’re always adding an ‘extra blade’ to their ‘razor’ or ‘micro-cleansing beads’ to their ‘toothpaste’. Annuities are a perfect example. The first annuity in America was offered in 1759. The first variable annuity was offered by TIAA-CREF in 1952 for use easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi in college retirement programs. The purpose of the variable annuity was to allow a teacher to grow their nest egg during their working years and then convert that growth into a steady income stream when they retired. In effect, they were creating their ow nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically n pension. You would have a hard time recognizing that product today. A guaranteed minimum death benefit was introduced in 1980. The guarantee minimum income benefit in 1996, enhance earnings benefits in 2000, the guaranteed minimum withdrawal benefit and and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ the guaranteed minimum account balance in 2002. With each ‘improvement’ the costs have gone up as well. Whereas variable annuities used to be a low-cost way to create your own pension, now they are bloated, expensive all-things-to-all-people products off ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ering every bell and whistle you can imagine. The total cost associated with variable annuities can quickly climb to 3% or more with just the basic features—higher if you add all the ‘benefits’. The main purpose of a variable annuity is to provide greater ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a returns then a fixed-annuity. All these costs make that much harder to achieve. Moreover, these costs essentially are transferring a large portion of the growth from your nest egg to the insurance company. Worse, few of these benefits are ever used. The dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod key selling point of a variable annuity is supposed to be a lifetime income stream, but less than 5% of variable contracts are ever annuitized. If they are a long-term vehicle designed to save for retirement, why are so many being sold to people already r cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin etired? Why are 70 and 80-year olds being sold variable annuities? I say ‘being sold’ because only 2% of people choose to buy an annuity on their own. The rest are sold by banks, brokers and agents. Could the fact that the commission is so high be a cause tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ? Call me old-fashioned. I still shave with a two-blade razor. It works well and saves me money. If you want the traditional benefits of a variable annuity, choose the two-blade kind. They are the low-cost, plain vanilla variable annuities sold by compani t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel es like Vanguard. You already know what next year’s Super Bowl advertisement will be: a razor with six blades! And you know what your commission-based advisor will be pushing soon: an investment with another costly feature! Don’t fall for it! Ignore the h ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ype. Find low-cost solutions to your financial goals and keep control of your money Have a financial question? Send me an email and I’ll personally respond, free of charge. Go to www.guardingyourwealth.com and click on "Ask Jeff". SPECIAL REPORT: Over 8 y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products 0% of equity-indexed annuities purchased in America come from
Allianz, which skims billions of dollars per year from unsuspecting
folks (most of whom are seniors) all over the country. Chances are very good that you, or someone you know, has been pitc . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de hed on
this particular product by an agent. In my brand new report (just
released), I pull back the curtain on the shady practices being used to
pawn this deceptive and deceitful product off on innocent investors. Click here for your complimentary c elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip opy: http://www.guardingyourwealth.com/SpecialReports/Allianz.htm In addition to being a nationally syndicated columnist and Certified Financial Planning Practitioner, Mr. Voudrie provides personal, private money management services to clients nationwide tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Constuction Job Site Safety Audit - 9 Common Construction Site Safety Issues How to Write an Effective Cover Letter How eBay Auction Templates Will Explode Sales
|